Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners

John S Dowden
Med J Aust 2004; 180 (6): . || doi: 10.5694/j.1326-5377.2004.tb05940.x
Published online: 15 March 2004

John S Dowden

  • Australian Prescriber, Suite 3/2 Phipps Close, Deakin, ACT 2600.


Competing interests:

Australian Prescriber is published by the National Prescribing Service. John Dowden is an unpaid director of Therapeutic Guidelines Ltd, and a member of the Editorial Advisory Board of the Australian Medicines Handbook.

  • 1. Juni P, Rutjes AW, Dieppe PA. Are selective COX-2 inhibitors superior to traditional non-steroidal anti-inflammatory drugs? BMJ 2002; 324: 1287-1288.
  • 2. Kerr SJ, Mant A, Horn FE, et al. Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners. Med J Aust 2003; 179: 403-407. <eMJA full text>
  • 3. MacDonald T, Morant S, Goldstein J, et al. Chanelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs. Gut 2003; 52: 1265-1270.
  • 4. National Institute for Clinical Excellence. Guidance on the use of cyclo-oxygenase (COX) II selective inhibitors, celecoxib, rofecoxib, meloxicam and etodolac for osteoarthritis and rheumatoid arthritis. London: NICE, 2001.
  • 5. Rostom A, Dube C, Jolicoeur E, et al. Gastroduodenal ulcers associated with the use of non-steroidal anti-inflammatory drugs: a systematic review of preventive pharmacological interventions. Ottawa: Canadian Coordinating Office for Health Technology Assessment, 2003.
  • 6. Solomon DH, Glynn RJ, Bohn R, et al. The hidden cost of non-selective non-steroidal anti-inflammatory drugs in older patients. J Rheum 2003; 30: 792-798.
  • 7. Kamath CC, Kremers M, Vanness DJ, et al. The cost-effectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritis. Value in Health 2003; 6: 144-157.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.